Archive

Celator(R) Pharmaceuticals Announces Appointment of Derek Miller as Chief Business Officer
December 3, 2013

CASMED Receives China Food and Drug Administration Approval for FORE-SITE(R) Cerebral Oximeter
November 25, 2013

InnoPharma Inc. Completes $20 Million Term Loan Facility
November 13, 2013

InnoPharma Inc. Appoints Vish Shetty as Vice President, Business Development & Alliance Management                                                                                                                               November 11, 2013

Zogenix Pursues Development Of Abuse Deterrent Formulations Of Zohydro(TM) ER With Altus Formulation
November 1, 2013

Zogenix Receives FDA Approval for Zohydro(TM) ER (hydrocodone bitartrate) Extend-Release Capsules
October 25, 2013

Auspex Appoints Pratik Shah As CEO And Expands Executive Team
October 17, 2013

CASMED Names Brian Wagner As Chief Commercial Officer
October 2, 2013

Zogenix Gets Pentagon Contract Worth Up To $20.7M
September 30, 2013

Celator® Pharmaceuticals Announces Start Of Clinical Study Of Cpx-351 In Pediatric, Adolescent And Young Adult Patients With Relapsed Or Refractory Hematologic Malignancies
September 19, 2013

CASMED Announces Initial Sales Of The Next-Generation FORE-SIGHT ELITE Cerebral Oximeter
September 12, 2013

Celator® Pharmaceuticals Announces Listing On OTCBB And OTC Link
September 12, 2013

Invitae Announces Results Of Hereditary Breast Cancer Study In Collaboration With Stanford University
September 7, 2013

Jeryl L. Hilleman Joins Ocera Therapeutics As Chief Financial Officer
September 3, 2013

Celator® Pharmaceuticals Receives U.S. Patent On Proprietary Liposome Composition
August 29, 2013

Celator® Pharmaceuticals Announces Start Of Clinical Study In Patients With Untreated Myelodysplastic Syndrome (Mds) Or Acute Myeloid Leukemia At High Risk Of Treatment-Related Mortality
August 13, 2013

Valeant Pharmaceuticals International, Inc. Completes Acquisition Of Bausch + Lomb
August 6, 2013

InnoPharma Inc. Appoints Deborah DuFresne As Vice President, Strategic Portfolio Selection & Management
August 5, 2013

Celator® Pharmaceuticals Appoints Michael R. Dougherty To Board Of Directors 
July 24, 2013

Ocera Therapeutics Announces Completion Of Merger With Tranzyme 
July 15, 2013

Auspex Initiates Phase 3 Trial of SD-809 In Huntington's Disease 
July 11, 2013

Clarus Therapeutics Bolsters Executive Team With Addition Of Chief Medical And Chief Scientific Officers 
July 1, 2013

CASMED Receives FDA Clearance for Next-Generation Vital Signs Monitor And Blood Pressure Solution 
June 4, 2013

Valeant Pharmaceuticals International, Inc. To Acquire Bausch + Lomb For $8.7 Billion 
May 27, 2013

Packaging Coordinators, Inc. Acquires AndersonBrecon From AmerisourceBergen 
May 13, 2013

Zogenix Reports Positive Top-Line Results From Extended Relday(™) Phase 1 Clinical Trial 
May 2, 2013

Celator® Pharmaceuticals Raises $32.5 Million Completing A $39.3 Million Private Placement Financing   
April 30, 2013

Thomas, McNerney & Partners Joins With National Venture Capital Association And Other Industry Leaders In Briefing Congress On Need For Policies That Will Support Investment In Medical Innovation   
April 25, 2013

Tranzyme Pharma And Ocera Therapeutics Announce Merger Agreement   
April 24, 2013

CASMED Announces FDA Approval Of Next Generation FORE-SIGHT® Absolute Tissue Oximeter   
April 17, 2013

Torax Medical's LINX® Reflux Management System Featured On USA Today   
April 11, 2013

Bausch + Lomb Files Registration Statement For Proposed Initial Public Offering   
March 22, 2013

Vertiflex®, Inc. Announces First Patient Successfully Treated With The Totalis™ Direct Decompression System   
March 18, 2013

InnoPharma Inc. Announces Launch Of Generic Cidofovir Injection In The United States    
March 8, 2013

The New England Journal Of Medicine Publishes Clinical Study Of Minimally-Invasive Device for Treatment Of Reflux Disease   
February 21, 2013

AxioMed’s Freedom Cervical Disk Implanted In Switzerland   
February 13, 2013

Vertiflex, Inc. Announces FDA Clearnace of Two Key Additions to Technology Portfolio         January 8, 2013

Tranzyme Pharma Annunces Successful Completion of Drug Discovery Collaboration With Bristol-Myers Squibb                                                                                                         January 4, 2013

Zogenix Reports Positive Results From Reiday (™) Phase 1 Clinical Trial                            January 3, 2013

Celator® Pharmaceuticals Announces Appointment Of Fred Powell As Chief Financial Officer   
December 18, 2012

Tranzyme Pharma Announces Top-Line Results Of TZP-102 Phase 2b Trial   
November 15, 2012

Auspex Pharmaceuticals Closes $25 Million Series D Financing   
November 8, 2012

Thomas, McNerney & Partners Invests In Keystone Dental, Inc.   
October 22, 2012

Cebix Announces Positive Results of ERSATTA Phase 1/2 Trial In Peripheral Neuropathy   
October 17, 2012

Mallinckrodt Completes Acquisition Of CNS Therapeutics, Inc.   
October 2, 2012

Clarus Therapeutics Top-line Results Show Oral Testosterone Replacement Candidate, CLR-610, Meets Phase 3 Study Primary Efficacy Endpoint    
September 25, 2012

Mallinckrodt Announces Definitive Agreement to Acquire CNS Therapeutics, Inc.   
September 24, 2012

Torax Medical Secures $30M Financing To Commercialize Pioneering Treatment For Reflux Disease   
September 19, 2012

Clarus Therapeutics Strengthens Patent Estate With Issuance Of A U.S. Patent Directed To Formulations And Method Of Use Of Clarus' Oral Testosterone Product   
September 19, 2012

Tranzyme Pharma Announces Exercise of Underwriters' Over-Allotment Option And Closing Of $11.5 Million Registered Direct Offering Of Common Stock   
September 18, 2012

Torax Medical Names Veteran Industry Executive To Lead Global Commercialization Effort   
September 12, 2012

BMO Capital Markets: Flash: Tranzyme Pharma 2Q12 Recap Highlights Progress In Diabetic Gastroparesis   
August 13, 2012

Locus Development, Inc. Merges With InVitae Division Of Genomic Health   
August 8, 2012

Zogenix Announces U.S. Food And Drug Administration (FDA) Acceptance For Review Of Zohydro ER(TM) New Drug Application (NDA) For Treatment Of Chronic Pain   
July 16, 2012

Zogenix Begins Relday(TM) Clinical Trial For Schizophrenia   
July 12, 2012

The Leukemia & Lymphoma Society And Celator Pharmaceuticals Announce $5 Million Partnership To Support Phase 3 Development Of CPX-351 For AML   
July 2, 2012

Mid-America Healthcare Investors Network (MHIN) Elects Kathleen Tune As President Of Its Board Of Directors   
July 1, 2012

AxioMed Spine Corporation Receives CE Mark For Freedom® Cervical Disc   
May 15, 2012

Zogenix Submits New Drug Application (NDA) To U.S. Food And Drug Administration (FDA) For Zohydro(TM) For Treatment Of Chronic Pain   
May 2, 2012

Clarus Therapeutics Completes Patient Enrollment In Phase 3 Study Of Its Proprietary Oral Testosterone Replacement Therapy  
May 1, 2012

Tioga Pharmaceuticals, Inc. Raises $10 Million To Advance Phase 3 Clinical Development Of Asimadoline In Irritable Bowel Syndrome 
April 12, 2012

FDA Approves LINX® System For The Treatment Of Reflux Disease 
March 27, 2012

SG Biofuels Completes $17 Million Series B Financing 
January 17, 2012

Torax Medical’s LINX® Reflux Management System Receives Unanimous Recommendation From FDA Advisory Panel 
January 13, 2012

VertiFlex®, Inc. Completes Enrollment of The Superion® Pivotal IDE Clinical Trial 
December 13, 2011

Momenta Pharmaceuticals Acquires Assets From Virdante Pharmaceuticals 
December 5, 2011

InnoPharma Completes $15 Million Series A Financing 
December 1, 2011

Zogenix Reports Positive Phase 3 Results for Zohydro -- Meets Primary Efficacy Endpoint 
August 17, 2011

Zogenix and DURECT Announce Development and License Agreement for Antipsychotic Product Candidate 
July 12, 2011

Zogenix Enters $30 Million Royalty Financing Agreement with Cowen Healthcare Royalty Partners II 
June 30, 2011

Cebix Initiates Phase 1b Clinical Trial with Drug Candidate Ersatta™ 
June 16, 2011

CASMED Raises $15 Million in Private Placement
June 9, 2011

Asante Solutions Receives FDA Clearance for Pearl™ Insulin Pump
May 17, 2011

Asante Solutions, Inc. Receives CE Mark for Pearl™ Insulin Pump
April 12, 2011

Boston Scientific Strengthens Structural Heart Product Portfolio by Completing Acquisition of Atritech
March 3, 2011

Tranzyme Pharma and Norgine Initiate Dosing in Phase 3 Pivotal Study of Novel Intravenous GI Motility Drug Ulimorelin
February 23, 2011

Thomas, McNerney & Partners Expands Team and Moves West Coast Office to San Diego
February 23, 2011

Zogenix Announces Completion of Enrollment in ZX002 Phase 3 Efficacy Study
February 10, 2011

VertiFlex®, Inc. Announces Financing and New Investment Partner
February 1, 2011

Thomas, McNerney & Partners Promotes Two Members of its Investment Team
January 25, 2011

Boston Scientific to Acquire Atritech
January 19, 2011

Quinnova Pharmaceuticals, Inc. Joins The Amneal Enterprises, LLC Alliance
December 20, 2010

Celator® Pharmaceuticals Raises $20 Million in Series D Financing
September 1, 2010

Sandoz Completes Acquisition of Oriel Therapeutics, Strengthening Potential for Global Leadership in Respiratory
June 3, 2010

Sandoz to Acquire Oriel Therapeutics, Gaining Rights to Portfolio of Respiratory Products Targeting Asthma and COPD
April 19, 2010

Intuity Medical Closes $64 Million Series D Financing - One of The Largest Medical Device Funding Events of 2009
January 5, 2010

Virdante Pharmaceuticals Secures Funding to Improve Antibody-Based Therapeutics for Autoimmune and Inflammatory Disorders
October 29, 2009

Michael Demane Joins Thomas, McNerney & Partners as Senior Advisor
April 3, 2009

Atritech Completes $30 Million Financing
March 25, 2009

Thomas, McNerney & Partners Promotes Three Members of Its Investment Team
January 8, 2009

Arkal Medical, Inc. Secures $17.5 Million in Series B Financing
September 16, 2008

Amarin Announces Private Placement for Up to $60 Million
May 14, 2008

Ocera Therapeutics Closes $35.5 Million Series C Financing
February 20, 2008

Wuxi Pharmatech to Acquire Apptec Laboratory Services, Inc.
January 3, 2008

Oriel $23 Million Richer: Firm Brings New Chairman
November 19, 2007

Pfizer to Acquire Coley Pharmaceutical Group
November 16, 2007

Tranzyme Pharma Closes New $20 Million Financing
November 1, 2007

Thomas, McNerney & Partners Expands Team on East and West Coasts
October 17, 2007

Isis Pharmaceuticals and Thomas, McNerney & Partners Announce that the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory Conditions
October 16, 2007

Thomas, McNerney & Partners Invests in Asante Solutions Inc.
January 12, 2007

Softscope Medical Technologies, Inc. Completes $4 Million Series A Financing
December 13, 2006

Galil Medical, a Leader in Cryotherapy Solutions, Announces $52 Million Financing
December 11, 2006

Thomas, McNerney & Partners Invests in Neurotherapeutics Pharma, Inc.
December 6, 2006

Quinnova Pharmaceuticals, Inc. Completes $13.6 Million Series A Financing
November 28, 2006

Thomas, McNerney & Partners Closes $375 Million Life Science & Medical Technology Fund
September 6, 2006

Zogenix, Inc. Created Through Aradigm Asset Sale of Intraject® Needle-Free Technology
August 28, 2006

Thomas, McNerney & Partners Is Lead Investor in Osteobiologics, Acquired By Smith & Nephew
July 11, 2006

Ocera Therapeutics Raises $12 Million Series B Financing
July 10, 2006

Ocera Therapeutics, a New Gastrointestinal and Liver-Focused Company, Raises $14.5m in Series A Financing
January 17, 2006

Coley Pharmaceutical Group Sets Price for Initial Public Offering
August 10, 2005

Torax Medical Completes $10 Million Series B Financing
June 28, 2005

Tranzyme Pharma Completes US$32 Million Financing
May 13, 2005

Coley Pharmaceutical Group Files Registration Statement for Proposed Initial Public Offering
April 20, 2005

Pfizer, Coley Pharmaceutical Group Enter Into Exclusive Global License for the Development and Commercialization of Promune for Cancers
March 24, 2005

Axiomed Spine Corporation Secures $18 Million in Series B Financing
February 21, 2005

Thomas McNerney & Partners Invests in Leptos Biomedical, Inc.
December 13, 2004

Thomas, McNerney & Partners Announces Pratik Shah, Ph.D. as New Venture Partner in San Francisco Office
November 8, 2004

Coley Pharmaceutical Group Raises $25 Million in Private Financing
September 29, 2004

Thomas, McNerney & Partners Invests in Solstice Neurosciences, Inc.
July 7, 2004

Thomas, McNerney & Partners Invests in Clarus Therapeutics, Inc.
February 13, 2004

Thomas, McNerney & Partners Invests in Intuity Medical Inc.
December 23, 2003

Osteobiologics, Inc. Closes $9.2 Million Financing
October 3, 2003

Coley Pharmaceutical Group Announces $35 Million Private Financing
August 25, 2003

Thomas, McNerney & Partners, LLC, Raises $216 Million for Its Inaugural Health Care Private Equity Fund
May 6, 2003